Osteonecrosis
1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
VericelIxmyelocel-T
MedactaMOTO Medial
Clinical Trials (2)
Total enrollment: 11 patients across 2 trials
Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head
Start: Sep 2007Est. completion: Dec 201011 patients
Phase 3Completed
MOTO Post-marketing Surveillance Study
Start: Sep 2019Est. completion: Mar 2023
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
3 companies competing in this space